Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 公司前身为开曼迈瑞医疗电子（深圳）有限公司，由迈瑞（开曼）有限公司于1999年出资设立。2001年10月18日，迈瑞有限股东会作出决议，同意以发起设立方式将迈瑞有限变更为股份有限公司，根据深圳天健信德会计师事务所出具的信德深特审报字（2001)第56号审计报告，将迈瑞有限截至2001年7月31日经审计的净资产86,265,839.55元中的86,000,000元折为迈瑞医疗86,000,000股（每股面值为人民币1元)，余额265,839.55元计入资本公积。迈瑞有限全体股东作为发起人，以各自在迈瑞有限中的权益所对应的净资产认购股份有限公司的股份。2001年12月18日，公司召开创立大会暨第一次股东大会，审议通过了关于迈瑞有限整体变更设立股份有限公司的相关议案。2001年12月26日，深圳市工商行政管理局向公司核发了变更为股份有限公司的《企业法人营业执照》。 公司主要从事医疗器械的研发、制造、营销及服务，始终以客户需求为导向，致力于为全球医疗机构提供优质产品和服务。公司融合创新，紧贴临床需求，支持医疗机构提供优质的医疗服务，从而帮助世界各地改善医疗条件、降低医疗成本。历经多年的发展，公司已经成为中国最大、全球领先的医疗器械以及解决方案供应商。公司总部设在中国深圳，在北美、欧洲、亚洲、非洲、拉美等地区的超过30个国家设有39家境外子公司；在国内设有17家子公司，超过40家分支机构，形成了庞大的全球化研发、营销及服务网络。公司主要产品涵盖三大领域：生命信息与支持、体外诊断以及医学影像，目前已拥有丰富的产品品类。
Main Business 从事医疗器械的研发、制造、营销及服务，始终以客户需求为导向，致力于为全球医疗机构提供优质产品和服务。
Legal Representative 李西廷
Top Executives
董事长：李西廷
副董事长：成明和
董事：徐航,成明和,吴昊,郭艳美
独立董事：孔昱,胡善荣,周先意,高圣平,许静,梁沪明
Top 5 Shareholder
Shareholder name Nature Holding Date
Smartco Development Limited流通A股26.98%30/09/2024
Magnifice(HK)Limited流通A股24.49%30/09/2024
香港中央结算有限公司流通A股12.01%30/09/2024
Ever Union(H.K.)Limited流通A股4.25%30/09/2024
中国工商银行股份有限公司－易方达创业板交易型开放式指数证券投资基金流通A股1.20%30/09/2024
Company Secretary 李文楣
Solicitors 上海市方达律师事务所
Auditors 普华永道中天会计师事务所（特殊普通合伙）
Tel No 0755-81888398
Fax No 0755-26582680-88398
Website www.mindray.com
Email ir@mindray. com
Company Address
Register: 广东省深圳市南山区高新技术产业园区科技南十二路迈瑞大厦1-4层
Office: 广东省深圳市南山区高新技术产业园区科技南十二路迈瑞大厦1-4层
Listing Date 16/10/2018
Shares Capital
Shares Capital: 1,215,691,266
Total A Share: 1,215,691,266
Listed A Share: 499,134,264
Non-tradable A Share: 716,557,002
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 9.559
DPS(RMB)* ¥ 5.800
NBV Per Share(RMB)* ¥ 27.288
Market Capitalization(RMB) 309.136B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.